BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s
For the second time this week, a contract research organization has come under fire for trial-conduct issues – criticism leveled most recently by Biovie Inc., which saw its...

More in BioWorld

BioWorld MedTech

Bivacor pumped by FDA IDE approval for total artificial heart study
“The FDA approval to begin the Bivacor Total Artificial Heart EFS is a critical milestone for Bivacor and is another validation of the remarkable work and accomplishments...

More in BioWorld MedTech

BioWorld Science

‘A trillion in each of us’: Flagship-backed Quotient takes on somatic genomics
Launching a company based on knowledge that “the fundamental principle that most people hold to be true is off by a trillion” is a rare opportunity, said Jake Rubens,...

More in BioWorld Science

BioWorld Asia

Innovent on a roll: China accepts two new NDAs for lung cancer
In less than one week, Innovent Biologics Inc. has seen two NDAs for non-small-cell lung cancer accepted for review by China’s National Medical Products Administration, and...

More in BioWorld Asia

BioWorld Insider Podcast

Google’s Scott Penberthy joins the podcast for a visionary discussion that scans the horizon for startling changes artificial intelligence will bring to drug development in the relatively near future.